Skip to content
10-K

Annual Report

Guardant Health, Inc. GH

0001576280-26-000013

← back to feed
Filed
Feb 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 13, 2026 131.17M sh
Shares Diluted FY 2025 · Dec 31, 2025 125.37M sh
Shares Diluted FY 2025 · Dec 31, 2024 122.75M sh
Shares Diluted FY 2025 · Dec 31, 2023 111.99M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $45.01M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $48.31M
Capex FY 2025 · Dec 31, 2024 $35.09M
Capex FY 2025 · Dec 31, 2023 $20.49M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$184.76M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$239.86M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$324.98M
Long Term Debt FY 2025 · Dec 31, 2025 $1.5B
Long Term Debt FY 2025 · Dec 31, 2024 $1.14B
Cash And Equivalents FY 2025 · Dec 31, 2025 $378.2M
Cash And Equivalents FY 2025 · Dec 31, 2024 $525.54M
Cash And Equivalents FY 2025 · Dec 31, 2023 $1.13B
Stockholders Equity FY 2025 · Dec 31, 2025 −$99.31M
Stockholders Equity FY 2025 · Dec 31, 2024 −$139.65M
Stockholders Equity FY 2025 · Dec 31, 2023 $158.68M
Stockholders Equity FY 2025 · Dec 31, 2022 $60.18M
Current Liabilities FY 2025 · Dec 31, 2025 $302.73M
Current Liabilities FY 2025 · Dec 31, 2024 $225.58M
Total Liabilities FY 2025 · Dec 31, 2025 $2.11B
Total Liabilities FY 2025 · Dec 31, 2024 $1.63B
Current Assets FY 2025 · Dec 31, 2025 $1.47B
Current Assets FY 2025 · Dec 31, 2024 $1.06B
Total Assets FY 2025 · Dec 31, 2025 $2.01B
Total Assets FY 2025 · Dec 31, 2024 $1.49B
Eps Diluted FY 2025 · Dec 31, 2025 −$3.32
Eps Diluted FY 2025 · Dec 31, 2024 −$3.56
Eps Diluted FY 2025 · Dec 31, 2023 −$4.28
Eps Basic FY 2025 · Dec 31, 2025 −$3.32
Eps Basic FY 2025 · Dec 31, 2024 −$3.56
Eps Basic FY 2025 · Dec 31, 2023 −$4.28
Sga Expense FY 2025 · Dec 31, 2025 $211.41M
Sga Expense FY 2025 · Dec 31, 2024 $180.12M
Sga Expense FY 2025 · Dec 31, 2023 $155.8M
Rd Expense FY 2025 · Dec 31, 2025 $364.19M
Rd Expense FY 2025 · Dec 31, 2024 $347.75M
Rd Expense FY 2025 · Dec 31, 2023 $367.19M
Net Income FY 2025 · Dec 31, 2025 −$416.28M
Net Income FY 2025 · Dec 31, 2024 −$436.37M
Net Income FY 2025 · Dec 31, 2023 −$479.45M
Operating Income FY 2025 · Dec 31, 2025 −$437.25M
Operating Income FY 2025 · Dec 31, 2024 −$443.59M
Operating Income FY 2025 · Dec 31, 2023 −$564.73M
Cost Of Revenue FY 2025 · Dec 31, 2025 $349.01M
Cost Of Revenue FY 2025 · Dec 31, 2024 $289.8M
Cost Of Revenue FY 2025 · Dec 31, 2023 $227.05M
Revenue FY 2025 · Dec 31, 2025 $982.02M
Revenue FY 2025 · Dec 31, 2024 $739.02M
Revenue FY 2025 · Dec 31, 2023 $563.95M